Berliner Boersenzeitung - First Covid vaccine side-effect claims land in German courts

EUR -
AED 4.104397
AFN 76.945413
ALL 99.231189
AMD 432.617988
ANG 2.010719
AOA 1036.724537
ARS 1074.259252
AUD 1.641361
AWG 2.011389
AZN 1.904081
BAM 1.955429
BBD 2.252673
BDT 133.324726
BGN 1.95472
BHD 0.42042
BIF 3234.286875
BMD 1.117438
BND 1.441627
BOB 7.709539
BRL 6.162788
BSD 1.115688
BTN 93.249023
BWP 14.748204
BYN 3.651208
BYR 21901.788071
BZD 2.248874
CAD 1.517202
CDF 3208.165381
CHF 0.950204
CLF 0.037689
CLP 1039.944272
CNY 7.880067
CNH 7.870123
COP 4641.820049
CRC 578.89026
CUC 1.117438
CUP 29.612111
CVE 110.244101
CZK 25.088056
DJF 198.672338
DKK 7.466767
DOP 66.967305
DZD 147.657009
EGP 54.142736
ERN 16.761573
ETB 129.466357
FJD 2.459262
FKP 0.850995
GBP 0.839107
GEL 3.051043
GGP 0.850995
GHS 17.539675
GIP 0.850995
GMD 76.548818
GNF 9639.172699
GTQ 8.624365
GYD 233.395755
HKD 8.704949
HNL 27.675753
HRK 7.597474
HTG 147.212093
HUF 393.517458
IDR 16941.25656
ILS 4.221139
IMP 0.850995
INR 93.284241
IQD 1461.522939
IRR 47035.770303
ISK 152.262556
JEP 0.850995
JMD 175.286771
JOD 0.791709
JPY 160.803866
KES 143.922717
KGS 94.13132
KHR 4531.14103
KMF 493.181764
KPW 1005.693717
KRW 1488.975611
KWD 0.340897
KYD 0.929724
KZT 534.908597
LAK 24636.329683
LBP 99909.860054
LKR 340.395471
LRD 223.1377
LSL 19.586187
LTL 3.299505
LVL 0.675928
LYD 5.297996
MAD 10.818149
MDL 19.468309
MGA 5046.04342
MKD 61.603322
MMK 3629.395577
MNT 3797.054841
MOP 8.955702
MRU 44.337595
MUR 51.268486
MVR 17.164273
MWK 1934.433289
MXN 21.697078
MYR 4.698871
MZN 71.348848
NAD 19.586187
NGN 1831.984424
NIO 41.062216
NOK 11.713438
NPR 149.198716
NZD 1.791484
OMR 0.429669
PAB 1.115688
PEN 4.181807
PGK 4.367172
PHP 62.188829
PKR 309.994034
PLN 4.274593
PYG 8704.349913
QAR 4.067529
RON 4.972492
RSD 117.203662
RUB 103.07316
RWF 1504.014883
SAR 4.193134
SBD 9.282489
SCR 14.578236
SDG 672.143165
SEK 11.364797
SGD 1.442952
SHP 0.850995
SLE 25.530448
SLL 23432.113894
SOS 637.579134
SRD 33.752262
STD 23128.713955
SVC 9.762149
SYP 2807.596846
SZL 19.593286
THB 36.793929
TJS 11.859752
TMT 3.911034
TND 3.380559
TOP 2.617156
TRY 38.132438
TTD 7.588561
TWD 35.736832
TZS 3045.822602
UAH 46.114158
UGX 4133.216465
USD 1.117438
UYU 46.101261
UZS 14197.308611
VEF 4047978.463464
VES 41.096875
VND 27494.566096
VUV 132.664504
WST 3.125992
XAF 655.832674
XAG 0.035881
XAU 0.000426
XCD 3.019933
XDR 0.826843
XOF 655.832674
XPF 119.331742
YER 279.722751
ZAR 19.426272
ZMK 10058.288435
ZMW 29.537401
ZWL 359.814634
  • CMSD

    0.0100

    25.02

    +0.04%

  • RBGPF

    58.8300

    58.83

    +100%

  • BTI

    -0.1300

    37.44

    -0.35%

  • NGG

    0.7200

    69.55

    +1.04%

  • SCS

    -0.3900

    12.92

    -3.02%

  • GSK

    -0.8200

    40.8

    -2.01%

  • RYCEF

    0.0200

    6.97

    +0.29%

  • RIO

    -1.6100

    63.57

    -2.53%

  • CMSC

    0.0300

    25.15

    +0.12%

  • BP

    -0.1200

    32.64

    -0.37%

  • RELX

    -0.1400

    47.99

    -0.29%

  • BCC

    -7.1900

    137.5

    -5.23%

  • AZN

    -0.5200

    78.38

    -0.66%

  • JRI

    -0.0800

    13.32

    -0.6%

  • BCE

    -0.1500

    35.04

    -0.43%

  • VOD

    -0.0500

    10.01

    -0.5%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

(H.Schneide--BBZ)